Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
IndiaTimes
0 shares
1 views
You might like
Related news coverage
Zydus Cadila gets nod for phase 3 trials of its COVID-19 vaccine candidate
The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country's first DNA vaccine candidate..
Mid-Day
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine
Vaccine ZyCoV-D was found to be safe, well-tolerated and immunogenic in phase I and II clinical trials
Hindu